These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 12510468
1. Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas? Gray M, Jacobson T. J Wound Ostomy Continence Nurs; 2002 Sep; 29(5):228-33. PubMed ID: 12510468 [No Abstract] [Full Text] [Related]
2. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog. Kocak S, Bumin C, Karayalcin K, Alacayir I, Aribal D. Dig Dis; 1994 Sep; 12(1):62-8. PubMed ID: 8200125 [Abstract] [Full Text] [Related]
4. Severe hyperglycemia following transition from octreotide to lanreotide in a patient with enterocutaneous fistula receiving parenteral nutrition. Rosen AN, Balazh JR, Franck AJ. Nutr Clin Pract; 2022 Jun; 37(3):727-731. PubMed ID: 34462966 [Abstract] [Full Text] [Related]
5. Octreotide for enterocutaneous fistulas of Crohn's disease. Lavy A, Yasin K. Can J Gastroenterol; 2003 Sep; 17(9):555-8. PubMed ID: 14532930 [Abstract] [Full Text] [Related]
6. [Value of octreotide in the treatment of postoperative enterocutaneous fistula]. Sleth JC, Andraos Y, Borie F, Dumay R, Legroux P. Ann Fr Anesth Reanim; 1994 Sep; 13(5):738-40. PubMed ID: 7733526 [Abstract] [Full Text] [Related]
8. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Li-Ling J, Irving M. Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865 [Abstract] [Full Text] [Related]
9. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Martineau P, Shwed JA, Denis R. Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537 [Abstract] [Full Text] [Related]
10. Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis. Coughlin S, Roth L, Lurati G, Faulhaber M. World J Surg; 2012 May; 36(5):1016-1029. PubMed ID: 22419412 [Abstract] [Full Text] [Related]
11. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. Alvarez C, McFadden DW, Reber HA. World J Surg; 2000 May; 24(5):533-7; discussion 538. PubMed ID: 10787072 [Abstract] [Full Text] [Related]
12. Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula. Stevens P, Foulkes RE, Hartford-Beynon JS, Delicata RJ. Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):912-22. PubMed ID: 21814141 [Abstract] [Full Text] [Related]
14. Somatostatin in gastroenterology. More studies needed. Carlson GL, Scott NA, Irving MH, Sancho JJ, Sitges-Serra A. BMJ; 1994 Sep 03; 309(6954):604-5. PubMed ID: 7993463 [No Abstract] [Full Text] [Related]
15. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas]. Brunaud L, Sebbag H, Marchal F, Verdier A, Bresler L, Tortuyaux JM, Boissel P. Ann Chir; 2001 Feb 03; 126(1):34-41. PubMed ID: 11255969 [Abstract] [Full Text] [Related]
16. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites. Grauer L, Barkin JS. Digestion; 1994 Feb 03; 55 Suppl 1():24-8. PubMed ID: 7907566 [Abstract] [Full Text] [Related]
17. Treatment of high output enterocutaneous fistulas with a somatostatin analogue and famotidine. Kusunoki M, Shoji Y, Okamoto T, Kusuhara K, Sakanoue Y, Utsunomiya J. Eur J Surg; 1992 Aug 03; 158(8):443-5. PubMed ID: 1356486 [No Abstract] [Full Text] [Related]
18. Role of somatostatin analogues in the management of enterocutaneous fistulae. Jamil M, Ahmed U, Sobia H. J Coll Physicians Surg Pak; 2004 Apr 03; 14(4):237-40. PubMed ID: 15228830 [Abstract] [Full Text] [Related]